Welcome to Dr. Jungjoon Lee’s
Genome Re-InnovaTion LAB
Home
GRIT-LAB Developing Next-Generation CRISPR Technologies
research
GRIT-LAB BELIEVES THAT GENOME-EDITING PLATFORM TECHNOLOGY’S RE-INNOVATION IS ENDLESS.
The first semiconductor hit the market in 1954 and earned a Nobel Prize in 1956, paving the way for continuous innovations, including today’s AI chips that are transforming the world. Similarly, the first commercial monoclonal antibody drug, approved in 1986 following a Nobel Prize in 1984, set the stage for advancements like Antibody Drug Conjugation, which is revolutionizing the field. More recently in 2023, the first CRISPR drug, which won the Nobel Prize in 2020, was approved. At GRIT-Lab, we are confident that our scientists will continue to this legacy of innovation, developing groundbreaking platform technologies in the decades to come.
members
GRIT-LAB SERVES AS AN INCUBATOR FOR SCIENTISTS WITH A VARIETY OF CAREER GOALS.
Genome editing is a versatile technology of the future, attracting a wide range of employers interested in hiring scientists in this field. At GRIT-Lab, we aim to undertake multidisciplinary projects that enable our scientists to engage with colleagues from various sectors, reflecting on their own interests and unique qualities. Furthermore, we are committed to supporting our members transform their ideas into tangible outcomes that extend beyond the laboratory.
publications
GRIT-LAB IS COMMITTED TO PUBLISHING IMPACTFUL RESEARCH ACROSS MULTIPLE DISCIPLINES
Here at GRIT-Lab, we are committed to advancing the field of genome editing and fostering collaboration across diverse sectors beyond academia as we actively engage with industry partners, clinicians, regulatory authorities, and fellow researchers to drive impact and innovation.
seeking partners
At GRIT-Lab, a valued member of the Synthetic Biology for Clinical and Technological Innovation (SynCTI) Program at the National University of Singapore (NUS), we are dedicated to harnessing the power of collaboration to advance the field of genome editing.
